{"id":30489,"date":"2024-09-16T14:50:17","date_gmt":"2024-09-16T09:20:17","guid":{"rendered":"https:\/\/fundsindia.com\/blog\/?p=30489"},"modified":"2024-09-16T15:21:24","modified_gmt":"2024-09-16T09:51:24","slug":"alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2","status":"publish","type":"post","link":"https:\/\/www.fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489","title":{"rendered":"Alpha | Rainbow Children\u2019s Medicare Ltd. &#8211; Equity Research Desk"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept.png\"><img loading=\"lazy\" width=\"1024\" height=\"512\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-1024x512.png\" alt=\"\" class=\"wp-image-30491\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-1024x512.png 1024w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-300x150.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-768x384.png 768w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-1536x768.png 1536w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept.png 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Rainbow Children\u2019s Medicare Ltd &#8211; It takes a lot to treat the little<\/span><\/h2>\n\n\n\n<p>Incorporated in 1998 and headquartered in Hyderabad, Rainbow Children\u2019s Medicare Ltd. is a leading paediatric and perinatal care hospital chain in India. With 19 hospitals and 4 clinics across 6 cities, Rainbow has a bed capacity of 1,935 and employs around 4,000 permanent staff and 800+ doctors, offering comprehensive healthcare services from fertility, maternal care, and paediatrics to gynaecology.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-14.png\"><img loading=\"lazy\" width=\"748\" height=\"500\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-14.png\" alt=\"\" class=\"wp-image-30493\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-14.png 748w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-14-300x201.png 300w\" sizes=\"(max-width: 748px) 100vw, 748px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Products and Services<\/span><\/h2>\n\n\n\n<ul><li>Paediatric Services: Under \u201cRainbow Children\u2019s Hospital\u201d brand, it offers paediatric intensive care, multi-specialty services, and quaternary care, including organ transplantation.<\/li><li>Women Care Services: Branded as \u201cBirthright by Rainbow,\u201d it provides perinatal care, genetic care, fertility treatments, and gynaecology services.<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-15.png\"><img loading=\"lazy\" width=\"820\" height=\"303\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-15.png\" alt=\"\" class=\"wp-image-30494\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-15.png 820w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-15-300x111.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-15-768x284.png 768w\" sizes=\"(max-width: 820px) 100vw, 820px\" \/><\/a><\/figure>\n\n\n\n<p><strong>Subsidiaries<\/strong>: The company does not have any subsidiaries, joint ventures, or associate companies as of FY24.<\/p>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Growth Strategies<\/span><\/h2>\n\n\n\n<ul><li><strong>Hub-and-Spoke Model<\/strong>: The company operates super-speciality hubs in cities with 1-2 hospitals (150-250 beds) and regional spokes (50-100 beds) for primary and secondary care.<\/li><li><strong>Expansion Plans<\/strong>: Rainbow is developing new spoke hospitals in Bengaluru (60 beds), Andhra Pradesh (100 beds), and Coimbatore, with 2 hospitals planned for Gurugram (400 beds total).<\/li><li><strong>Operational Efficiency<\/strong>: By expanding its network and optimizing resources, Rainbow enhances market penetration and improves patient outcomes.<\/li><li><strong>Pilot Projects<\/strong>: The launch of the Adult Vaccination Outreach Program (AVON) with major vaccine manufacturers in FY24 marks the company\u2019s entry into new service areas.<\/li><\/ul>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Financial Performance<\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/Revenue-Breakup-FY24-_-Total-Revenue-FY24-Rs.1297-crore.png\"><img loading=\"lazy\" width=\"783\" height=\"530\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/Revenue-Breakup-FY24-_-Total-Revenue-FY24-Rs.1297-crore.png\" alt=\"\" class=\"wp-image-30495\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/Revenue-Breakup-FY24-_-Total-Revenue-FY24-Rs.1297-crore.png 783w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/Revenue-Breakup-FY24-_-Total-Revenue-FY24-Rs.1297-crore-300x203.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/Revenue-Breakup-FY24-_-Total-Revenue-FY24-Rs.1297-crore-768x520.png 768w\" sizes=\"(max-width: 783px) 100vw, 783px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\"><strong>Q1FY25<\/strong>:<\/span><\/h2>\n\n\n\n<ul><li>Revenue: \u20b9330 crore (+15% YoY)<\/li><li>EBITDA: \u20b994 crore (+7% YoY)<\/li><li>Net profit: \u20b940 crore (-5% YoY)<\/li><li>Occupancy rate: 42%<\/li><\/ul>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\"><strong>FY24<\/strong>:<\/span><\/h2>\n\n\n\n<ul><li>Revenue: \u20b91,297 crore (+10% YoY)<\/li><li>Operating Profit: \u20b9429 crore (+7% YoY)<\/li><li>Net profit: \u20b9218 crore (+3% YoY)<\/li><li>Bed capacity added: 280 beds<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-16.png\"><img loading=\"lazy\" width=\"751\" height=\"348\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-16.png\" alt=\"\" class=\"wp-image-30496\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-16.png 751w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-16-300x139.png 300w\" sizes=\"(max-width: 751px) 100vw, 751px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Financial Performance (FY21-24)<\/span><\/h2>\n\n\n\n<ul><li>Revenue CAGR (FY21-24): 26%<\/li><li>PAT CAGR (FY21-24): 75%<\/li><li>Average ROE &amp; ROCE (3 years): 22% each<\/li><li>Debt-to-equity ratio: 0.61<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-17.png\"><img loading=\"lazy\" width=\"749\" height=\"210\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-17.png\" alt=\"\" class=\"wp-image-30497\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-17.png 749w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-17-300x84.png 300w\" sizes=\"(max-width: 749px) 100vw, 749px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Industry outlook\u00a0<\/span><\/h2>\n\n\n\n<ul><li>The Indian healthcare sector is expanding rapidly, driven by medical tourism, high-end diagnostic services, and increased investment from public and private sectors.<\/li><li>Growing medical tourism due to India\u2019s cost-competitiveness attracts patients from across the world.<\/li><li>Strengthened healthcare coverage and increased expenditure continue to fuel industry growth.<\/li><\/ul>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Growth Drivers<\/span><\/h2>\n\n\n\n<ul><li><strong>Healthcare Budget<\/strong>: Healthcare Budget: \u20b990,659 crore allocated under the Interim Union Budget 2024-25, up by 1.69%.<\/li><li><strong>FDI<\/strong>: 100% FDI is allowed for greenfield projects.<\/li><li><strong>Hospital Market<\/strong>: Projected to grow from US$ 98.98 billion in 2023 to US$ 193.59 billion by 2032 at a CAGR of 8%.<\/li><li><strong>Paediatric Market<\/strong>: Expected CAGR of 14% from FY20-26.<\/li><\/ul>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Competitive Advantage<\/span><\/h2>\n\n\n\n<p>Rainbow\u2019s superior return on equity (ROE) and capital employed (ROCE) surpass competitors like Max Healthcare and Fortis Healthcare, showcasing operational efficiency and profitability.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-18.png\"><img loading=\"lazy\" width=\"1024\" height=\"149\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-18-1024x149.png\" alt=\"\" class=\"wp-image-30498\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-18-1024x149.png 1024w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-18-300x44.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-18-768x112.png 768w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-18.png 1434w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Outlook<\/span><\/h2>\n\n\n\n<ul><li>Rainbow is positioned to capture growth opportunities in the paediatric and maternity healthcare sectors through its hub-and-spoke model.<\/li><li>The expansion of its hospital network and the proven success of the model in Hyderabad are expected to sustain growth.<\/li><li>Plans to replicate the model nationwide are in progress.<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-19.png\"><img loading=\"lazy\" width=\"1024\" height=\"712\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-19-1024x712.png\" alt=\"\" class=\"wp-image-30499\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-19-1024x712.png 1024w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-19-300x208.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-19-768x534.png 768w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-19.png 1226w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><\/figure>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Valuation<\/span><\/h2>\n\n\n\n<p>The large addressable market of paediatrics and maternity care is expected to have a strong growth trajectory in the future, and we expect Rainbow with its established position and futuristic business strategies to grow in tandem with the market. We recommend a BUY rating in the stock with a target price (TP) of Rs.1,558, 53x FY26E EPS.<\/p>\n\n\n\n<h2><span class=\"has-inline-color has-vivid-cyan-blue-color\">Risks<\/span><\/h2>\n\n\n\n<ul><li>Regulatory changes can impact cash flows in the highly regulated healthcare sector.<\/li><li>Intense competition may dilute market share.<br><\/li><\/ul>\n\n\n\n<p><em><strong>Note:<\/strong> Please note that this is not a recommendation and is intended only for educational purposes. So, kindly consult your financial advisor before investing.<\/em><\/p>\n\n\n\n<p dir=\"ltr\" style=\"line-height: 1.8; margin-top: 0pt; margin-bottom: 0pt; text-align: center;\"><a href=\"https:\/\/fundsindia-marketing-assets.s3.ap-south-1.amazonaws.com\/alpha-Rainbow-Childrens-Medicare-Ltd-Sep-2024-updated.docx.pdf\" rel=\"noopener\"><img alt=\"\" src=\"https:\/\/fundsindia-marketing-assets.s3.ap-south-1.amazonaws.com\/button_read-the-full-alpha-report.png\" style=\"width: 320px; height: 49px;\"><\/a><\/p>\n\n\n\n<h2><strong><span class=\"has-inline-color has-vivid-cyan-blue-color\">Recap of our previous recommendations (As on 13 September 2024)<\/span><\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-20.png\"><img loading=\"lazy\" width=\"928\" height=\"214\" src=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-20.png\" alt=\"\" class=\"wp-image-30500\" srcset=\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-20.png 928w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-20-300x69.png 300w, https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/image-20-768x177.png 768w\" sizes=\"(max-width: 928px) 100vw, 928px\" \/><\/a><\/figure>\n\n\n\n<p><a href=\"https:\/\/www.fundsindia.com\/blog\/equities\/alpha-epl-ltd-equity-research-desk\/30441\">EPL Ltd<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fundsindia.com\/blog\/equities\/alpha-epigral-ltd-equity-research-desk\/30366\">Epigral Ltd<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fundsindia.com\/blog\/equities\/alpha-mankind-pharma-ltd-equity-research-desk\/30325\">Mankind Pharma Ltd<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.fundsindia.com\/blog\/equities\/alpha-action-construction-equipment-ltd-equity-research-desk\/30290\">Action Construction Equipment Ltd<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rainbow Children\u2019s Medicare Ltd &#8211; It takes a lot to treat the little Incorporated in 1998 and headquartered in Hyderabad, Rainbow Children\u2019s Medicare Ltd. is a leading paediatric and perinatal care hospital chain in India. With 19 hospitals and 4 clinics across 6 cities, Rainbow has a bed capacity of 1,935 and employs around 4,000 [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":30501,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[743,59],"tags":[744,1033,745,1063,897,1092,892,648,1091,870],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v17.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>RAINBOW Stock Analysis September - 2024 | ALPHA<\/title>\n<meta name=\"description\" content=\"Rainbow Children\u2019s Medicare can grow with its hub-and-spoke model, expanding network, and solid financials; BUY rating with a target price of Rs.1,558.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RAINBOW Stock Analysis September - 2024 | ALPHA\" \/>\n<meta property=\"og:description\" content=\"Rainbow Children\u2019s Medicare can grow with its hub-and-spoke model, expanding network, and solid financials; BUY rating with a target price of Rs.1,558.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489\" \/>\n<meta property=\"og:site_name\" content=\"Insights\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/fundsindia\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-16T09:20:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-16T09:51:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"150\" \/>\n\t<meta property=\"og:image:height\" content=\"150\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Equities Desk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\",\"name\":\"Wealth India Financial Services\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/fundsindia\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"contentUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg\",\"width\":189,\"height\":200,\"caption\":\"Wealth India Financial Services\"},\"image\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/\",\"name\":\"Insights\",\"description\":\"Official blog of FundsIndia.com\",\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png\",\"contentUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png\",\"width\":150,\"height\":150},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#webpage\",\"url\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489\",\"name\":\"RAINBOW Stock Analysis September - 2024 | ALPHA\",\"isPartOf\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#primaryimage\"},\"datePublished\":\"2024-09-16T09:20:17+00:00\",\"dateModified\":\"2024-09-16T09:51:24+00:00\",\"description\":\"Rainbow Children\\u2019s Medicare can grow with its hub-and-spoke model, expanding network, and solid financials; BUY rating with a target price of Rs.1,558.\",\"breadcrumb\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fundsindia.com\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alpha | Rainbow Children\\u2019s Medicare Ltd. &#8211; Equity Research Desk\"}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#article\",\"isPartOf\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#webpage\"},\"author\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656\"},\"headline\":\"Alpha | Rainbow Children\\u2019s Medicare Ltd. &#8211; Equity Research Desk\",\"datePublished\":\"2024-09-16T09:20:17+00:00\",\"dateModified\":\"2024-09-16T09:51:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#webpage\"},\"wordCount\":572,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png\",\"keywords\":[\"Alpha\",\"fundamental analysis\",\"FundsIndia Equity Research\",\"FundsIndia insights\",\"Growth Drivers\",\"healthcare\",\"Industry Analysis\",\"outlook\",\"Rainbow Childrens Medicare Ltd\",\"valuation\"],\"articleSection\":[\"Alpha\",\"Equity Research\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656\",\"name\":\"Equities Desk\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.fundsindia.com\/blog\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g\",\"caption\":\"Equities Desk\"},\"sameAs\":[\"http:\/\/www.fundsindia.com\"],\"url\":\"https:\/\/www.fundsindia.com\/blog\/author\/equities-desk\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RAINBOW Stock Analysis September - 2024 | ALPHA","description":"Rainbow Children\u2019s Medicare can grow with its hub-and-spoke model, expanding network, and solid financials; BUY rating with a target price of Rs.1,558.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489","og_locale":"en_US","og_type":"article","og_title":"RAINBOW Stock Analysis September - 2024 | ALPHA","og_description":"Rainbow Children\u2019s Medicare can grow with its hub-and-spoke model, expanding network, and solid financials; BUY rating with a target price of Rs.1,558.","og_url":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489","og_site_name":"Insights","article_publisher":"https:\/\/www.facebook.com\/fundsindia","article_published_time":"2024-09-16T09:20:17+00:00","article_modified_time":"2024-09-16T09:51:24+00:00","og_image":[{"width":150,"height":150,"url":"https:\/\/fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png","type":"image\/png"}],"twitter_misc":{"Written by":"Equities Desk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Organization","@id":"https:\/\/www.fundsindia.com\/blog\/#organization","name":"Wealth India Financial Services","url":"https:\/\/www.fundsindia.com\/blog\/","sameAs":["https:\/\/www.facebook.com\/fundsindia"],"logo":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#logo","inLanguage":"en-US","url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","contentUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2018\/07\/download.jpeg","width":189,"height":200,"caption":"Wealth India Financial Services"},"image":{"@id":"https:\/\/www.fundsindia.com\/blog\/#logo"}},{"@type":"WebSite","@id":"https:\/\/www.fundsindia.com\/blog\/#website","url":"https:\/\/www.fundsindia.com\/blog\/","name":"Insights","description":"Official blog of FundsIndia.com","publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fundsindia.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#primaryimage","inLanguage":"en-US","url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png","contentUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png","width":150,"height":150},{"@type":"WebPage","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#webpage","url":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489","name":"RAINBOW Stock Analysis September - 2024 | ALPHA","isPartOf":{"@id":"https:\/\/www.fundsindia.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#primaryimage"},"datePublished":"2024-09-16T09:20:17+00:00","dateModified":"2024-09-16T09:51:24+00:00","description":"Rainbow Children\u2019s Medicare can grow with its hub-and-spoke model, expanding network, and solid financials; BUY rating with a target price of Rs.1,558.","breadcrumb":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fundsindia.com\/blog"},{"@type":"ListItem","position":2,"name":"Alpha | Rainbow Children\u2019s Medicare Ltd. &#8211; Equity Research Desk"}]},{"@type":"Article","@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#article","isPartOf":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#webpage"},"author":{"@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656"},"headline":"Alpha | Rainbow Children\u2019s Medicare Ltd. &#8211; Equity Research Desk","datePublished":"2024-09-16T09:20:17+00:00","dateModified":"2024-09-16T09:51:24+00:00","mainEntityOfPage":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#webpage"},"wordCount":572,"commentCount":0,"publisher":{"@id":"https:\/\/www.fundsindia.com\/blog\/#organization"},"image":{"@id":"https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#primaryimage"},"thumbnailUrl":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png","keywords":["Alpha","fundamental analysis","FundsIndia Equity Research","FundsIndia insights","Growth Drivers","healthcare","Industry Analysis","outlook","Rainbow Childrens Medicare Ltd","valuation"],"articleSection":["Alpha","Equity Research"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fundsindia.com\/blog\/equities\/alpha-rainbow-childrens-medicare-ltd-equity-research-desk-2\/30489#respond"]}]},{"@type":"Person","@id":"https:\/\/www.fundsindia.com\/blog\/#\/schema\/person\/78222a5d6aef66b1f386dfa767382656","name":"Equities Desk","image":{"@type":"ImageObject","@id":"https:\/\/www.fundsindia.com\/blog\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2620d09063050fc426411ab6ea46fc72?s=96&d=mm&r=g","caption":"Equities Desk"},"sameAs":["http:\/\/www.fundsindia.com"],"url":"https:\/\/www.fundsindia.com\/blog\/author\/equities-desk"}]}},"jetpack_featured_media_url":"https:\/\/www.fundsindia.com\/blog\/wp-content\/uploads\/2024\/09\/rainbow-hospital-16-sept-150x150-1.png","_links":{"self":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/30489"}],"collection":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/comments?post=30489"}],"version-history":[{"count":2,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/30489\/revisions"}],"predecessor-version":[{"id":30502,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/posts\/30489\/revisions\/30502"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/media\/30501"}],"wp:attachment":[{"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/media?parent=30489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/categories?post=30489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fundsindia.com\/blog\/wp-json\/wp\/v2\/tags?post=30489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}